Screenshots

Description

Study 200195 App’s purpose is to support GSK Study 200195 (Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID) Registry for Patients Treated with Strimvelis™ (or GSK269273) Gene Therapy: Long-Term Prospective, Non-Interventional Follow-up of Safety and Effectiveness). Registry participant’s will be able to use the app to enter the required information for the study.

Information

Provider
Glaxo SmithKline PLC
Size
54.8 MB
Category
Medical
Compatibility

Requires iOS 9.0 or later. Compatible with iPhone, iPad and iPod touch.

Languages

English

Age Rating
Rated 12+ for the following:
Infrequent/Mild Medical/Treatment Information
Copyright
© GSK PLC
Price
Free

Supports

  • Family Sharing

    Up to six family members will be able to use this app with Family Sharing enabled.

More By This Developer